We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $15.1B
1-Year Est. Return 27.93%
This Fund
S&P 500
This Quarter Est. Return
-0.71%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
AUM
$3.54B
AUM Growth
+$107M
Cap. Flow
+$179M
Cap. Flow %
5.05%
Top 10 Hldgs %
20.31%
Holding
4,474
New
404
Increased
1,575
Reduced
1,479
Closed
707
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARAY icon
3701
Accuray
ARAY
$32.7M
$23 ﹤0.01%
+30
New +$19
CIX icon
3702
Comp X International
CIX
$394M
$23 ﹤0.01%
+1
New +$24
GPRO icon
3703
GoPro
GPRO
$111M
$23 ﹤0.01%
6
-24
-80% -$24
GWRS icon
3704
Global Water Resources
GWRS
$263M
$23 ﹤0.01%
+24
New +$202
LUNG icon
3705
Pulmonx
LUNG
$102M
$23 ﹤0.01%
+3
New +$5
LVWR icon
3706
LiveWire
LVWR
$277M
$23 ﹤0.01%
+3
New +$7
SES icon
3707
SES AI
SES
$194M
$23 ﹤0.01%
14
-10
-42% -$17
WALD icon
3708
Waldencast
WALD
$172M
$23 ﹤0.01%
+18
New +$29
WVE icon
3709
Wave Life Sciences
WVE
$993M
$23 ﹤0.01%
58
+44
+314% +$573
AARD
3710
Aardvark Therapeutics
AARD
$127M
$23 ﹤0.01%
+24
New +$249
VINP icon
3711
Vinci Compass Investments Ltd
VINP
$622M
$22 ﹤0.01%
2
SBFG icon
3712
SB Financial Group
SBFG
$173M
$21 ﹤0.01%
+5
New +$106
SKIL icon
3713
Skillsoft
SKIL
$62.1M
$21 ﹤0.01%
+1
New +$6
SKYX icon
3714
SKYX Platforms
SKYX
$164M
$21 ﹤0.01%
+5
New +$10
SBC
3715
SBC Medical Group
SBC
$417M
$21 ﹤0.01%
+19
New +$79
CRVO icon
3716
CervoMed
CRVO
$39.3M
$20 ﹤0.01%
14
+9
+180% +$47
PYXS icon
3717
Pyxis Oncology
PYXS
$269M
$20 ﹤0.01%
1
-13
-93% -$20
MPLT
3718
MapLight Therapeutics
MPLT
$584M
$20 ﹤0.01%
+5
New +$89
BVFL icon
3719
BV Financial
BVFL
$181M
$19 ﹤0.01%
+1
New +$19
VRA icon
3720
Vera Bradley
VRA
$94.1M
$19 ﹤0.01%
6
EVC icon
3721
Entravision Communication
EVC
$745M
$18 ﹤0.01%
+2
New +$6
MCRB icon
3722
Seres Therapeutics
MCRB
$51.3M
$18 ﹤0.01%
6
+4
+200% +$47
MRAM icon
3723
Everspin Technologies
MRAM
$403M
$18 ﹤0.01%
22
+20
+1,000% +$220
REKR icon
3724
Rekor Systems
REKR
$75.5M
$18 ﹤0.01%
2
-39
-95% -$42
SPWH icon
3725
Sportsman's Warehouse
SPWH
$45.3M
$18 ﹤0.01%
2
-11
-85% -$15

Similar funds

Arax Advisory Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Arax Advisory Partners held 4,474 positions worth $3.54B, up 3.1% from $3.43B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Arax Advisory Partners deployed $179M of net new capital in Q1 2026, opening 404 new positions and adding to 1,575 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 70% of assets, up from 68% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $32.9M trimmed.

  • Arax Advisory Partners's largest Q1 2026 buy was FT Vest US Equity Moderate Buffer ETF August: 789,886 shares worth $30.6M.
  • Arax Advisory Partners added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $59M increase.
  • Arax Advisory Partners's biggest Q1 2026 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $32.9M.
  • Arax Advisory Partners fully exited Willis Towers Watson in Q1 2026, selling an estimated $746K.
  • Arax Advisory Partners's ten largest holdings make up 20% of its $3.54B portfolio in Q1 2026.
  • Arax Advisory Partners opened 404 new positions and closed 707 in Q1 2026.
  • Arax Advisory Partners's portfolio value rose 3.1% quarter-over-quarter to $3.54B.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.